Indeed, metformin alters the energetic activity of cancer cells by downregulating the expression of HIF-1α and mTOR, by limiting the activity of the protumor isoform HK2 and by inhibiting complex 1 of the electron transport chain [149,150,151]. The gene discussed is MTOR; the disease is cancer.